Enzo Biochem, Inc. (NYSE:ENZ) Q3 2020 Earnings Conference Call June 8, 2020 5:00 PM ET Company Participants Barry Weiner - President David Bench - Chief Financial Officer Operator Good afternoon, and welcome to the Enzo Biochem Inc. Fiscal Third Quarter 2020 Operating Results Conference Call. I will now read the company's Safe Harbor statements. Except for historical information, the matters discussed in this news release maybe considered forward-looking statements within the meaning of Section 27A of the S ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark one x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2020 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) New York 13-2866202 (State or Other Jurisdiction ...

Enzo Biochem, Inc. (NYSE:ENZ) Q1 2020 Earnings Conference Call December 10, 2019 4:30 PM ET Company Participants Barry Weiner - President Conference Call Participants Richard Miller - La Bella Miller Properties Operator Good afternoon, and welcome to the Enzo Biochem Inc. Fiscal First Quarter 2020 Operating Results Conference Call. I will now read the company's Safe Harbor statement. Except for historical information, the matters discussed in the news release maybe considered forward-looking statements with ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark one x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended October 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) New York ...

Enzo Biochem, Inc. (NYSE:ENZ) Q4 2019 Earnings Conference Call October 15, 2019 4:30 PM ET Company Participants Barry Weiner - President Conference Call Participants Operator Good afternoon and welcome to the Enzo Biochem Inc. Fourth Quarter and Fiscal Year 2019 Operating Results Conference Call. I will now read the company's Safe Harbor statement. Except for historical information, the matters discussed in this news release maybe considered forward-looking statements within the meaning of Section 27A of th ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark one) x ANNUAL REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended July 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ______________ to ______________ Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) | --- | --- | --- | --- | |-- ...

Enzo Biochem, Inc. (NYSE:ENZ) Q3 2019 Results Earnings Conference Call June 11, 2019 8:30 AM ET Company Participants Barry Weiner - President, Chief Financial Officer, Principal Accounting Officer and Director Conference Call Participants Per Ostlund - Craig Hallum Operator Good morning, and welcome to the Enzo Biochem Inc. Third Quarter 2019 Operating Results Conference Call. I will now read the company's Safe Harbor statement. Except for historical information, the matters discussed in this news release ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark one x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended April 30, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) of Incorpo ...

Enzo Biochem, Inc. (NYSE:ENZ) Q2 2019 Earnings Conference Call March 12, 2019 8:30 AM ET Company Participants Barry Weiner - President, Chief Financial Officer, Principal Accounting Officer and Director James O'Brien - Executive Vice President, Finance Conference Call Participants Per Ostlund - Craig Hallum Operator Good morning, and welcome to the Enzo Biochem Inc. Second Quarter 2019 Operating Results Conference Call. I will now read the Company's Safe Harbor statement. Except for historical information, ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q Mark one x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended January 31, 2019 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________________ to ___________________ Commission File Number 001-09974 ENZO BIOCHEM, INC. (Exact name of registrant as specified in its charter) New York ...